Answers are grounded in this paper and cite their sources.
Multiple Sclerosis (MS) is a chronic demyelinating disease of the Central Nervous System (CNS) that manifests with inflammation and axonal degeneration.We decided to perform a meta-analysis to pool all available results of the association between IL-10 (!1082G/A) polymorphism and MS risk.This is a genetic meta-analysis conducted with respect to the association between the IL-10 polymorphism and MS risk.We accomplished a search in PubMed and Scopus databases to identify articles published up to Jun 2013 that examined the associations between IL-10 (1082 G/A) polymorphism and MS.Odds Ratios (OR) with the 95% Confidence Intervals (CI) were used to assess the association.A total of eight case-control studies, including 1517 cases and 1059 controls were selected.All the proposed models were associated with a non-significant increased risk of MS.The A allele carriers (homo and heterozygotes) had a 50% non-significant increased risk of MS, when compared with the homozygote G (OR = 1.50, 95% CI = 0.91-2.48,p = 0.111).In the subgroup analysis by ethnicity, non-significant increased MS risks were found among Europeans for all genetic models and the A allele carriers (homo and heterozygotes) had a 59% non-significant increased risk of MS (OR = 1.59, 95% CI = 0.91-2.79,p = 0.104).For Asian ethnicity (Iran), also no significant association between this polymorphism and MS risk was observed in all comparison models.This meta-analysis provided evidence that IL-10 (!1082 G/A) polymorphism is associated with an increased risk of MS, especially in Europeans.Current knowledge is not sufficient to explain the role of the aforementioned polymorphisms in MS pathogenesis.
No takes yet. Share an insight, caveat, or question.
Galehdari et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: